Argentus Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15,393
Closed -$1.82M 264
2016
Q3
$1.82M Buy
15,393
+3,244
+27% +$394K 0.64% 18
2016
Q2
$1.47M Buy
12,149
+774
+7% +$87.9K 0.63% 21
2016
Q1
$1.23M Buy
11,375
+429
+4% +$44.4K 0.43% 54
2015
Q4
$1.12M Sell
10,946
-75,335
-87% -$7.58M 0.35% 66
2015
Q3
$8.05M Sell
86,281
-29,311
-25% -$2.84M 1.2% 13
2015
Q2
$11.3M Buy
115,592
+1,497
+1% +$150K 1.71% 7
2015
Q1
$11.5M Buy
114,095
+1,221
+1% +$124K 1.81% 7
2014
Q4
$11.8M Buy
112,874
+20,607
+22% +$2.17M 1.98% 6
2014
Q3
$9.84M Buy
92,267
+34,596
+60% +$3.59M 1.58% 8
2014
Q2
$6.03M Buy
57,671
+3,128
+6% +$316K 1.58% 16
2014
Q1
$5.36M Buy
54,543
+1,400
+3% +$130K 1.3% 14
2013
Q4
$4.87M Buy
53,143
+1,290
+2% +$119K 1.03% 15
2013
Q3
$4.5M Sell
51,853
-626
-1% -$56.2K 1.04% 17
2013
Q2
$4.51M Buy
+52,479
New +$4.45M 1.07% 14

Other funds holding JNJ

Argentus Capital Management's JNJ Position: Q4 2016 in Review

Argentus Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2016, closing a stake of 15,393 shares — an estimated $1.82M sold.

Argentus Capital Management first reported a position in JNJ in Q2 2013 and held it in 14 quarters. The position peaked at $11.8M in Q4 2014. 2,320 funds tracked by Wall St. Rank hold JNJ as of Q4 2016.

  • Argentus Capital Management reported no remaining Johnson & Johnson position as of Q4 2016 after selling out during the quarter.
  • Argentus Capital Management sold 15,393 Johnson & Johnson shares in Q4 2016, an estimated $1.82M.
  • Argentus Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 14 quarters.
  • Argentus Capital Management's Johnson & Johnson position peaked at $11.8M in Q4 2014.
  • 2,320 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.